惠每资本（HM Capital）是高瓴资本集团生态中专注于医疗健康投资的垂直基金，依托于亚洲私募股权基金巨头及国际顶尖医疗机构的生态圈优势，多维度、立体化地投资于医疗健康生态系统，致力于打造具有国际视野及本土执行力的专业投资平台，帮助早期和成长期医疗健康企业实现快速成长。
我们与高速成长中的创新型医疗健康企业紧密合作，以全球化的视角，为每一个成员提供完善的战略性增值服务和系统化赋能，与卓越的创业者们分享惠每资本在全球的商业网络与资源体系。
Company Details
- Employees
- 16
- Founded
- 2018
- Address
- 新源南路3号平安金融中心b座2202-2203室, 3号,china
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.huimeicap.com
- Keywords
- GurryShark Capital.
- HQ
- 北京, 北京
惠每资本 Questions
惠每资本's website is http://www.huimeicap.com
惠每资本's LinkedIn profile is https://cn.linkedin.com/company/%E6%83%A0%E6%AF%8F%E8%B5%84%E6%9C%AC
惠每资本 has
16 employees.
View email and phone details for 16
employees at 惠每资本.
惠每资本's industry is
Venture Capital and Private Equity Principals
惠每资本's top competitors are
Cd Capital,
Bayland Capital 康君资本,
Med-Fine Capital,
Gurryshark Capital,
Hm Venture Partners,
Muse Capital,
Qiming Venture Partners,
Synapto Ventures,
Vivo Capital,
China Renaissance 华兴资本.
惠每资本's categories are Venture Capital and Private Equity Principals
惠每资本's founding year is 2018
